Minimally invasive surgery of pathological nipple discharge with contrast-enhanced ultrasound

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045029

Enrollment

Unknown

Registered

2021-04-03

Start date

2021-04-05

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast nipple discharge

Interventions

Treatment group:Surgery

Eligibility

Sex/Gender

Female

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Female patients aged between 18 and 75 years; 2.Patients with pathological nipple discharge requiring surgical intervention; 3.Participants are required to participate in this clinical trial voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant women; 2.Breast cancer patients with pathologically confirmed; 3.Patents participated in clinical trials of other devices or drugs within one month; 4.Patients who cannot tolerate surgery or voluntarily give up surgical treatment due to dysfunction of heart, brain, lung and other important organs; 5.Patients deemed unsuitable for this clinical trial by the investigator.

Design outcomes

Primary

Measure	Time frame
Postoperative pathology;Length of incision;Postoperative cosmetic effect of patients;Evaluation of patient satisfaction;	—

Countries

China

Contacts

Public ContactGao Yinguang

Beijing Friendship Hospital, Capital Medical University

gaoyinguang@163.com+86 13691099801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026